Sun Pharma reported consolidated revenue growth of 14.7% for Q2 FY27, led by its Semiconductors division, which contributed 19.2% of the total. Operating margin held at 11.4%, a few basis points below the previous quarter as higher logistics and wage costs offset operating leverage.

Risks were not ignored. Executives flagged input-cost volatility, potential delays in environmental clearances for the new plant and the possibility of tougher competition from lower-priced imports. They said a pricing-pass-through mechanism covers about 60 percent of exposure.

The numbers

A new long-term agreement with JSW Steel anchors a portion of the expansion. The deal covers multi-year supply at index-linked pricing, with volume commitments that provide a floor, and includes a joint development programme for higher-specification products with better margins.

Environmental, social and governance targets also featured. The company reiterated its goal to reduce emissions intensity by a third by 2032, and disclosed that 19.2% of electricity at its main sites now comes from renewable sources under long-term contracts.

On the post-results call, management said the order book now stands at $7.6 billion, equivalent to roughly 14 months of revenue, with about a third from export customers in Singapore and Indonesia. The chief financial officer described visibility as the best in five years.

“Visibility is worth more than growth. We can plan investments when we can see 14 months ahead.”

Expansion and capital allocation

Analysts were broadly constructive. Of 18 brokerages covering the stock, 12 maintain buy ratings, with target prices implying about 19.2% upside. The more cautious voices pointed to a valuation premium and the execution risk inherent in a large expansion programme.

Export performance was a bright spot. Shipments to Singapore rose 14.7%, helped by certification wins and shorter lead times from Mundra. Management said it would deepen its presence in the market by adding a local warehouse and a technical service team.

Customers, contracts and exports

Employees and communities are part of the plan: a skills academy near the new site will train 2,000 technicians over three years, funded jointly with the state government. Management said local hiring is a condition of the incentives it has received.

The company also announced a new facility near Mundra, designed to add about 1,201 tonnes of annual capacity and create roughly 1,200 jobs. Construction begins next quarter, and first production is targeted within 20 months. The plant will be built to meet European environmental standards.

Risks and analyst view

Balance-sheet metrics remain comfortable. Net debt to earnings stood at 0.8 times, and the company retired $200 million of high-cost borrowings during the quarter. Credit analysts say the improvement leaves room to fund the expansion without equity dilution.